These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4066906)

  • 1. Sensitivity of age-decline resistant ("hold") WAIS subtests to Alzheimer's disease.
    Larrabee GJ; Largen JW; Levin HS
    J Clin Exp Neuropsychol; 1985 Oct; 7(5):497-504. PubMed ID: 4066906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The WAIS-R profile: a diagnostic tool for Alzheimer's disease?
    Logsdon RG; Teri L; Williams DE; Vitiello MV; Prinz PN
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):892-8. PubMed ID: 2592529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fuld's formula and WAIS subtests in differential diagnosis of dementia.
    Caffarra P; Scaglioni A; Malvezzi L; Girotti F; Soliveri P; Musicco M; Previdi P
    Funct Neurol; 1991; 6(1):23-7. PubMed ID: 2055547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing between vascular dementia and Alzheimer's disease by means of the WAIS: a meta-analysis.
    Oosterman JM; Scherder EJ
    J Clin Exp Neuropsychol; 2006 Oct; 28(7):1158-75. PubMed ID: 16840242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education and cognitive function in Alzheimer's disease.
    Filley CM; Cullum CM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jan; 10(1):48-51. PubMed ID: 9118196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WAIS-R subtest profile and cortical perfusion in Alzheimer's disease.
    Alexander GE; Prohovnik I; Stern Y; Mayeux R
    Brain Cogn; 1994 Jan; 24(1):24-43. PubMed ID: 8123262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.
    Satz P; Van Gorp WG; Soper HV; Mitrushina M
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):767-74. PubMed ID: 3693533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
    Satz P; Hynd GW; D'Elia L; Daniel MH; Van Gorp W; Connor R
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):759-65. PubMed ID: 2258435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function and frontal lobe atrophy in normal elderly adults: Implications for dementia not as aging-related disorders and the reserve hypothesis.
    Meguro K; Shimada M; Yamaguchi S; Ishizaki J; Ishii H; Shimada Y; Sato M; Yamadori A; Sekita Y
    Psychiatry Clin Neurosci; 2001 Dec; 55(6):565-72. PubMed ID: 11737788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clock drawing test in mild and moderate dementia of the Alzheimer's type: a comparative and correlation study.
    Heinik J; Solomesh I; Shein V; Becker D
    Int J Geriatr Psychiatry; 2002 May; 17(5):480-5. PubMed ID: 11994938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type.
    Haxby JV; Raffaele K; Gillette J; Schapiro MB; Rapoport SI
    J Clin Exp Neuropsychol; 1992 Jul; 14(4):575-92. PubMed ID: 1400920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of new WAIS-III/WMS-III discrepancy scores for evaluating memory functioning: relationship between intellectual and memory ability.
    Lange RT; Chelune GJ
    J Clin Exp Neuropsychol; 2006 May; 28(4):592-604. PubMed ID: 16624786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wechsler Intelligence Scale profiles, the cholinergic system, and Alzheimer's disease.
    Filley CM; Kobayashi J; Heaton RK
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):180-6. PubMed ID: 3558750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests.
    Tröster AI; Butters N; Salmon DP; Cullum CM; Jacobs D; Brandt J; White RF
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):773-88. PubMed ID: 8276935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.
    Almkvist O; Tallberg IM
    Neuropsychology; 2009 Jan; 23(1):117-24. PubMed ID: 19210039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criterion validation of premorbid intelligence estimation in persons with traumatic brain injury: "hold/don't hold" versus "best performance" procedures.
    Hoofien D; Vakil E; Gilboa A
    J Clin Exp Neuropsychol; 2000 Jun; 22(3):305-15. PubMed ID: 10855039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.